Design, Synthesis, and Antitumor Activity Evaluation of Novel Lupeol-3-urea/thiourea Derivatives

T. C. Xu,R. Luo,Z. X. Chen,J. Song,H. X. Cui,X. Hong,Y. L. Han,M. Bu,M. Wang
DOI: https://doi.org/10.1134/s1070363224100207
2024-11-27
Russian Journal of General Chemistry
Abstract:A series of novel lupeol-3-urea/thiourea derivatives were designed, synthesized and evaluated for their in vitro anticancer activity against human lung cancer A549, human hepatocellular carcinoma HepG2 and human breast cancer MCF-7 cell lines. The antitumor activities of all compounds were higher than that of parent Lupeol. Among them, lup-20(29)-en-3β-yl-piperazinecarboxylate-(2,4-fluorophenyl)urea showed the strongest antitumor activity against A549 cell lines, with an IC 50 of 3.22 μM, which is tenfold than that of Lupeol. Therefore, lup-20(29)-en-3β-yl-piperazinecarboxylate-(2,4-fluorophenyl)urea can be used as a new lead compound for the development of more potent antitumor drugs.
chemistry, multidisciplinary
What problem does this paper attempt to address?